12427401

Kuscu NK

2002

Celiac disease and polycystic ovary syndrome.

12428204

Dewailly D

2002

Nonclassic 21-hydroxylase deficiency.

12437490

Glueck CJ

2002

The contentious nature of gestational diabetes: diet, insulin, glyburide and metformin.

12439532

Kauffman RP

2002

Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations.

12442087

Thorin-Savour? A

2002

[Hyperandrogenism and pregnancy].

12444089

Pandey AV

2003

Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17.

12447098

Laven JS

2002

New approach to polycystic ovary syndrome and other forms of anovulatory infertility.

12447099

Hayes EC

2002

COX-2 inhibitors and their role in gynecology.

12452306

Alpaslan M

2002

QT dispersion in patients with polycystic ovary syndrome.

12456596

Stadtmauer LA

2002

Should patients with polycystic ovary syndrome be treated with metformin? Benefits of insulin sensitizing drugs in polycystic ovary syndrome--beyond ovulation induction.

12456627

Winter E

2002

Early pregnancy loss following assisted reproductive technology treatment.

12457445

Xita N

2002

The genetic basis of polycystic ovary syndrome.

12459231

Amesse LS

2002

From HAIR-AN to eternity.

12460327

Dixon JB

2002

Neck circumference a good predictor of raised insulin and free androgen index in obese premenopausal women: changes with weight loss.

12461500

Onyemere KU

2002

Parental history and early-onset type 2 diabetes in African Americans and Latinos in Chicago.

12466349

Jakimiuk AJ

2002

Estrogen receptor alpha and beta expression in theca and granulosa cells from women with polycystic ovary syndrome.

12466353

Welt CK

2002

Serum inhibin B in polycystic ovary syndrome: regulation by insulin and luteinizing hormone.

12466363

Pagotto U

2002

Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels.

12466392

Cibula D

2002

Prediction of insulin sensitivity in nonobese women with polycystic ovary syndrome.

12466732

Kuscu NK

2002

Insulin and oral antidiabetic agents for treatment of polycystic ovary syndrome.

12467025

Lara HE

2002

Changes in sympathetic nerve activity of the mammalian ovary during a normal estrous cycle and in polycystic ovary syndrome: Studies on norepinephrine release.

12468195

American Collegeof Obstetricians and Gynecologists.

2002

ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists: number 41, December 2002.

12470331

Tan SL

2002

In-vitro maturation of oocytes from unstimulated polycystic ovaries.

12470526

Fatemi HM

2002

Rescue IVF and coasting with the use of a GnRH antagonist after ovulation induction.

12475548

Simpson JL

2002

Molecular approach to common causes of female infertility.

12476794

Minoia P

2001

Metabolic control through L calcium channel, PKC and opioid receptors modulation by an association of naloxone and calcium salts.

12477299

Rasgon NL

2002

Common treatment of polycystic ovarian syndrome and major depressive disorder: case report and review.

12477505

Agrawal R

2002

Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries.

12477506

Meldrum DR

2002

Vascular endothelial growth factor, polycystic ovary syndrome, and ovarian hyperstimulation syndrome.

12477517

la Marca A

2002

Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome.

12477518

Siegel S

2002

A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome.

12477536

Wang HQ

2002

Mutational analysis of the m?llerian-inhibiting substance gene and its receptor gene in Japanese women with polycystic ovary syndrome and premature ovarian failure.

12477538

Erel CT

2002

Leptin receptor variant in women with polycystic ovary syndrome.

12482943

Paruthiyil S

2002

Phosphodiesterase expression targeted to gonadotropin-releasing hormone neurons inhibits luteinizing hormone pulses in transgenic rats.

12485434

Bataille V

2002

The influence of genetics and environmental factors in the pathogenesis of acne: a twin study of acne in women.

12485460

Reynolds LP

2002

Angiogenesis in the female reproductive organs: pathological implications.

12489565

Trimarchi CP

2002

Cyclic estrogen-progestin hormone therapy as a new therapeutic approach in the treatment of functional alterations of the hypothalamus-pituitary-ovary axis: case reports.

12490665

Ness-Abramof R

2002

Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.

12497688

Karabakhtsian R

2002

Malignant mixed mesodermal tumor in a young woman with polycystic ovary syndrome. A case report.

12498424

Filicori M

2002

The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction.

12498425

Delvigne A

2002

Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review.

12502516

Urbanek M

2003

Variation in resistin gene promoter not associated with polycystic ovary syndrome.

12503891

J?rvel? IY

2002

Characterization of normal and polycystic ovaries using three-dimensional power Doppler ultrasonography.

12510993

Legro RS

2002

Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome.

12517726

Araya AV

2002

Evaluation of tumor necrosis factor alpha production in ex vivo short term cultured whole blood from women with polycystic ovary syndrome.

12518752

Munson BL

2002

Myths and facts...about polycystic ovarian syndrome.

12519843

Taponen S

2003

Hormonal profile of women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland birth cohort 1966 study.

12519844

Morin-Papunen L

2003

Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.

12519859

Cermik D

2003

Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome.

12521896

Ko?ak I

2001

Treatment of chronic anovulation resistant to clomiphene citrate (CC) by using gonadotrophin-releasing hormone agonist (GnRH-a) ovarian suppression followed by recombinant follicle-stimulating hormone (r-hFSH) treatment (Suprecur, Puregon).

12524053

Costello MF

2003

A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome.

12524094

Villuendas G

2003

Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome.

12525441

Ib??ez L

2003

Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome.

12527343

O'Brien PE

2002

The extent of the problem of obesity.

12527345

Dixon JB

2002

Selecting the optimal patient for LAP-BAND placement.

12536355

McCartney CR

2002

Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.

12547664

Quint EH

2002

Hirsutism and adnexal masses in a teenager.

12548323

Foster WG

2003

Do environmental contaminants adversely affect human reproductive physiology?

12549723

Marx TL

2003

Polycystic ovary syndrome: pathogenesis and treatment over the short and long term.

12551775

Goumenou AG

2003

The role of leptin in fertility.

12554240

El-Sheikhah A

2002

Surgical induction of ovulation in polycystic ovarian disease.

12557616

Macut D

2002

Age and body mass related changes of cardiovascular risk factors in women with polycystic ovary syndrome.

12557812

Moran LJ

2002

The obese patient with infertility: a practical approach to diagnosis and treatment.

12559191

Sugerman HJ

2003

Bariatric surgery for severely obese adolescents.

12566751

Bjercke S

2002

Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome.

12568839

Yong PY

2003

A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment.

12568857

Vigan? A

2003

Hyperinsulinemia induced by highly active antiretroviral therapy in an adolescent with polycystic ovary syndrome who was infected with human immunodeficiency virus.

12570169

Parsanezhad ME

2002

A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.

12571165

George SS

2003

Sequential treatment of metformin and clomiphene citrate in clomiphene-resistant women with polycystic ovary syndrome: a randomized, controlled trial.

12573809

Miller WL

2002

Androgen biosynthesis from cholesterol to DHEA.

12574183

Paradisi G

2003

Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.

12574198

Orio F Jr

2003

Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome.

12574218

Moran LJ

2003

Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome.

12574237

Orio F Jr

2003

Circulating ghrelin concentrations in the polycystic ovary syndrome.

12577127

Shalev E

2003

Gonadotropin-releasing hormone and reproductive medicine.

12577345

Li DJ

2001

[Summary of National Academic Conference on emmeniopathy and infertility of integrated traditional Chinese and Western medicine].

12577406

Resch M

2002

[Gynecologic and obstetric complications in eating disorders].

12580842

Cresswell J

2003

Relationship between polycystic ovaries, body mass index and insulin resistance.

12587529

Ku?cu NK

2002

Insulin: does it induce follicular arrest in the rat ovary?

12593902

Yildirim M

2003

Ovarian wedge resection by minilaparatomy in infertile patients with polycystic ovarian syndrome: a new technique.

12593999

Shobokshi A

2003

Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy.

12596340

Birchfield PC

2003

Women's health issues and the occupational health nurse's role.

12596342

Kelley LS

2003

Polycystic ovarian syndrome. A challenge for occupational health nursing.

12600116

Xu L

2001

[Polycystic ovaraian syndrome and hyperinsulinemia].

12604144

Trent ME

2003

Fertility concerns and sexual behavior in adolescent girls with polycystic ovary syndrome: implications for quality of life.

12615817

Seaman HE

2003

Differences in the use of combined oral contraceptives amongst women with and without acne.

12615818

Seaman HE

2003

The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case-control study.

12615821

Korhonen S

2003

Polymorphism in the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome.

12615832

Jonard S

2003

Ultrasound examination of polycystic ovaries: is it worth counting the follicles?

12619317

Domitrz J

2002

[Two treatment methods of infertility associated with polycystic ovarian syndrome].

12620424

Haas DA

2003

Effects of metformin on body mass index, menstrual cyclicity, and ovulation induction in women with polycystic ovary syndrome.

12620440

Ghazeeri G

2003

Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome.

12620441

Lahav-Baratz S

2003

Decreased expression of tissue inhibitor of matrix metalloproteinases in follicular fluid from women with polycystic ovaries compared with normally ovulating patients undergoing in vitro fertilization.

12620447

Elkind-Hirsch KE

2003

Concurrent ganirelix and follitropin beta therapy is an effective and safe regimen for ovulation induction in women with polycystic ovary syndrome.

12620454

Nardo LG

2003

Determination of the best-fitting ultrasound formulaic method for ovarian volume measurement in women with polycystic ovary syndrome.

12620464

Child TJ

2003

Ultrasonographic assessment of endometrial receptivity at embryo transfer in an in vitro maturation of oocyte program.

12620465

Cagnacci A

2003

Long-term response to naltrexone in polycystic ovary syndrome?

12620479

Ben-Shlomo I

2003

Regulation of matrix metalloproteinase-9 (MMP-9), tissue inhibitor of MMP, and progesterone secretion in luteinized granulosa cells from normally ovulating women with polycystic ovary disease.

12626030

Davis SR

2002

Preliminary indication of a high prevalence of polycystic ovary syndrome in indigenous Australian women.

12626031

Uncu G

2002

The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligomenorrheic patients without PCOS.